Did You Know...
...that several people are credited with the invention of the flush toilet? Most people have heard of Thomas Crapper (1837-1910), the sanitary engineer who invented the valve-and-siphon arrangement that made the modern toilet possible. Another claimant to "the throne" was British inventor Alexander Cumming who patented a toilet in 1775. Then there's a nameless Minoan (a native of ancient Crete) who lived 4,000 years ago who supposedly was ahead of his time and created the first flush toilet!
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8178125 | Oral formulations of glycyl-2-methylprolyl-glutamate Oral formulations of G-2MePE including microemulsions, coarse emulsions, liquid crystals, tablets and encapsulated forms of G-2MePE have improved bioavailability than conventional aqueous formulations. In particular, microparticles, nanoparticles and microemulsions ... | 05/15/2012 |
| 8158348 | Apparatus and method for preparative scale purification of nucleic acids Apparatus and methods are described for pharmaceutical grade manufacture extrachromosomal nucleic acids from cell lysates using flotation to separate and eliminate undesired insoluble cellular debris including chromosomal DNA from the lysates. A gas is introduced to... | 04/17/2012 |
| 8146893 | Apparatus and method for generating and tracing vortices Apparatus and methods for generating and tracing vortices include an actuator that is moved through a fluid is such a fashion as to produce a difference in pressure between two faces, so that the fluid is drawn from an area of higher pressure into an area of lower p... | 04/03/2012 |
| 8088630 | Nanoparticle and microparticle based detection of cellular products Embodiments of the present invention relate to devices and methods for detecting cellular products using detection particles having product-specific detection reagents and having a characteristic spectral feature. In particular, devices and methods are provided for ... | 01/03/2012 |
| 8081068 | Centre high mount stop lamp with constituent seatbelt disengagement indicator Embodiments of the invention detect and visually indicate to onlookers when a motor vehicle driver's and/or passenger's seatbelt is not engaged. An embodiment is comprised of control electronics, wiring, and an on-board Centre High Mount Stop Lamp (“CHMSL”) moun... | 12/20/2011 |
| 8075902 | Diagnosis and treatment of cancer related to human dormancy New devices and methods for diagnosis and compositions and methods for treatment of cancers use combinations of antimicrobial agents and agents that can reverse dormancy and hibernation pathways. We unexpectedly found that surprisingly low doses of anti-hibernation ... | 12/13/2011 |
| 8067425 | Neuroprotective bicyclic compounds and methods for their use Embodiments of this invention provide novel cyclic compounds structurally related to diketopiperazines and methods for their therapeutic use. Such compounds are neuroprotective and have utility as therapeutic agents for treatment of diseases, injuries and other cond... | 11/29/2011 |
| 7650236 | Means, methods, and apparatus to reduce the possibility of a motor vehicle entering a freeway ramp in the wrong direction of travel—towards oncoming traffic A system used to reduce the possibly of a vehicle entering a freeway ramp in the wrong direction of travel, towards oncoming traffic, is disclosed. The preferred system is comprised of equipment used in conjunction with orbiting satellite transceivers with receivers... | 01/19/2010 |
| 7563862 | Neural regeneration peptides and methods for their use in treatment of brain damage The invention discloses a family of peptides termed NRP compounds or NRPs that can promote neuronal migration, neurite outgrowth, neuronal proliferation, neural differentiation and/or neuronal survival, and provides compositions and methods for the use of NRPs in th... | 07/21/2009 |
| 7535401 | Activation of remote control transmitter functions by external inputs The ability to operate remote control transmitter functions from external sensors, in conjunction with internal or external controls, to provide condition dependant automatic control of devices such as digital video recorders and the like are presented. The system e... | 05/19/2009 |
| 7485630 | Neuroprotective macrocyclic compounds and methods for their use Embodiments of this invention provide novel peptidomimetics that contain a macrocycle. Such compounds are neuroprotective and have utility as therapeutic agents for treatment of diseases, injuries and other conditions characterised by neuronal degeneration and/or de... | 02/03/2009 |
| 7485298 | Diagnosis and treatment of human dormancy-related sequellae New methods for diagnosis and treatment of human dormancy syndrome-related sequellae are provided. Human dormancy syndrome (HDS) is characterized by elevated serum ratio of rT3/fT3 compared to a population of normal subjects. HDS includes fibromyalgia, chronic fatig... | 02/03/2009 |
| 7317840 | Methods for real-time software video/audio compression, transmission, decompression and display The invention presents new methods of compression, transmission, and decompression of video signals providing increased speed and image quality. Methods based on wavelet transformation with decimation and time stamping can provide one-pass encoding of signals in whi... | 01/08/2008 |
| 7304029 | Neuroprotective effect of growth hormone The invention relates to neuroprotection and to medicaments for use therein. Neuroprotection is induced by activation of neural growth hormone receptors, primarily using medicaments comprising growth hormone, growth hormone analogs or ligands which are functionally ... | 12/04/2007 |
| 7288257 | Diagnosis and treatment of human dormancy syndrome New methods for diagnosis of human dormancy syndrome are provided. Human dormancy syndrome is characterized by elevated serum ratio of rT3/fT3 compared to a population of normal subjects from which subjects suffering from fibromyalgia, chronic fatigue, obesity, deme... | 10/30/2007 |
| 7282342 | Methods for detecting weakly immunogenic analytes GPE antibodies recognize GPE with high specificity. When used in a radioimmunoassay, they reliably measure the concentration of GPE. They may be used to extend the half-life of GPE both in vivo and in vitro, and in methods of purifying the GPE receptor. Two methods ... | 10/16/2007 |
